Nitrogen

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which may render it contraindicated in certain circumstances. There are no reported teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For administration, Nitrogen is intended for use exclusively by or under the supervision of a licensed practitioner experienced in its use and administration.

The route of administration is via respiratory inhalation. The active ingredient is Nitrogen, provided in a concentration of 999 mL within a 1 L container.

Healthcare professionals should ensure that the administration is conducted in a controlled environment, adhering to established safety protocols and guidelines for inhalation therapies.

Contraindications

Use of this product is contraindicated in the following situations:

Handling should not occur until all safety precautions have been thoroughly read and understood. The product must be used and stored exclusively outdoors or in a well-ventilated area to mitigate risks associated with potential exposure. Additionally, it is essential to utilize equipment that is rated for cylinder pressure to ensure safety during use. Protection from sunlight is required when ambient temperatures exceed 52°C (125°F) to prevent degradation or hazardous conditions.

Warnings and Precautions

Administration of Nitrogen may pose significant hazards and is contraindicated in certain situations. It is imperative that this substance is used solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be well-versed in the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Nitrogen is classified as a gas under pressure and may explode if subjected to heat. Therefore, it is crucial to handle this substance with care. Users must ensure that all safety precautions are thoroughly read and understood prior to handling. Nitrogen may displace oxygen in the environment, leading to rapid suffocation; thus, it should only be used and stored outdoors or in a well-ventilated area.

To ensure safe usage, a backflow preventive device must be employed in the piping system. Equipment utilized must be rated for cylinder pressure to prevent accidents. It is essential to close the valve after each use and when the cylinder is empty. Additionally, protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F).

Prior to use, it is critical to read and follow the Safety Data Sheet (SDS) to understand the risks and safety measures associated with Nitrogen. In the event of inhalation, the affected individual should be removed to fresh air and kept comfortable for breathing. Medical advice or attention should be sought immediately.

Side Effects

Patients should be aware that exposure to this product may displace oxygen in the environment, potentially leading to rapid suffocation. This serious risk necessitates immediate action in the event of inhalation.

In the case of inhalation, it is critical to remove the affected individual to an area with fresh air and ensure they are comfortable while breathing. Medical advice and attention should be sought promptly to address any complications that may arise from exposure.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication. The prescribing information does not include recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the prescribing information regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated in certain situations. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must emphasize the warning that Nitrogen contains gas under pressure and may explode if heated. Patients should be informed that Nitrogen can displace oxygen, potentially leading to rapid suffocation. It is crucial that patients do not handle Nitrogen until they have read and understood all safety precautions.

Patients should be instructed to use and store Nitrogen exclusively outdoors or in a well-ventilated area. The use of a backflow preventive device in the piping is recommended to ensure safety. Additionally, patients must only utilize equipment that is rated for cylinder pressure and should close the valve after each use and when the cylinder is empty.

Healthcare providers should also inform patients to protect Nitrogen from sunlight when the ambient temperature exceeds 52°C (125°F) and to read and follow the Safety Data Sheet (SDS) prior to use. In the event of inhalation, patients should be advised to remove themselves to fresh air and maintain comfort for breathing, while seeking medical advice or attention as necessary.

Storage and Handling

The product is supplied in a manner that necessitates careful handling and storage. It must be used and stored exclusively outdoors or in a well-ventilated area to ensure safety. Protection from sunlight is essential when the ambient temperature exceeds 52°C (125°F).

After each use and when the product is empty, the valve should be securely closed. It is imperative to utilize a backflow preventive device in the piping to maintain system integrity. The equipment used must be rated for cylinder pressure to ensure safe operation.

Prior to handling, all safety precautions must be thoroughly read and understood to mitigate risks. When the product is empty, it should be returned to WEST PENN LACO, INC., located at 1830 Liverpool St., Pittsburgh, PA 15233.

Additional Clinical Information

No further data are available.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by WEST PENN LACO, INC.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)